Incretin Risks Lack Evidence, Says AACE

(MedPage Today) -- There currently is insufficient evidence of a definitive link between incretin diabetes medications and an increased risk of cancer, according to a consensus statement from the American Association of Clinical Endocrinologists.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news